The Effect of Osthole on Transient Receptor Potential Channels: A Possible Alternative Therapy for Atopic Dermatitis
Natalia Karolina Kordulewska,Angelika Król-Grzymała
DOI: https://doi.org/10.2147/jir.s425978
IF: 4.5
2024-02-10
Journal of Inflammation Research
Abstract:Natalia Karolina Kordulewska, Angelika Król-Grzyma&lstroka Department of Biochemistry, Faculty of Biology and Biotechnology, University of Warmia and Mazury, Olsztyn, 10-719, Poland Correspondence: Natalia Karolina Kordulewska, Oczapowskiego 1A, Olsztyn, 10-719, Poland, Tel +48 89 523 37 63, Fax +48 89 535 20 15, Email Introduction: Chronic recurrent skin inflammation and severe itching in patients with atopic dermatitis (AD) significantly impair their quality of life. The H4 histamine receptor plays a key role in histamine-induced itching. During the skin inflammation associated with AD, pro-inflammatory mediators (interleukins, cytokines) are released from neurons. Ultimately, a cascade of reactions leads to the activation and sensitization of transient receptor potential channels (TRP), which exacerbate the inflammation and itching associated with AD. Osthole (OST) is a natural coumarin with a proven versatile pharmacological effect: anti-cancer, anti-inflammatory and immunomodulatory. However, the molecular mechanism of OST in relieving inflammation in histamine-mediated itching is not yet clear. Purpose: In the studies presented, the possible effect of the OST action on the inhibition of the gene expression of the histamine H4 receptor and the key genes of the TRP channels as well as on the concentration of proinflammatory interleukins was analyzed. Methods: Inflammation was induced in a 3D skin model and a keratinocyte cell line Normal Human Epidermal Keratinocytes (NHEK) identical to that of AD, and then OST was administered at various doses. The concentrations of IL-4/-13 were determined by ELISA. RNA was isolated from the 3D skin cells and the NHEK cell line, and the qPCR method was used to determine the expression of: IL-4α, H4R, TRPV1, TRPV4, TRPM8 analyzed. Results: The study showed that OST significantly reduced the secretion of IL-4/-13 in a keratinocyte cell line and in a 3D skin model. In addition, OST was found to significantly decrease the gene expression of IL-4α, H4R, TRPV1, TRPV4 and increase TRPM8 in both the NHEK cell line and the organotypic 3D skin model. Conclusion: The data obtained provide the first in vitro evidence of itch relief following the application of OST to atopic skin. Research on the use of OST as an active component of emollients in the treatment of AD should be continued in the future. Keywords: pro-inflammatory cytokines, keratinocytes, clobetasol propionate, CP, TRPV channels, 3D skin Persistent recurrent skin inflammation and severe itching are characteristic of patients with atopic dermatitis (AD). 1–3 The molecular mechanism is not clear enough, even in patients for whom treatment brings relief. The fluctuating and unpredictable course of AD disease and the relatively limited number of approved drugs with an acceptable risk–benefit ratio continue to pose a major challenge in the treatment of the disease. As our understanding of AD disease evolves with increasing data on phenotypes, biomarkers and etiopathogenesis, we aim to leverage this knowledge to provide personalized treatment with existing and new therapies. 4,5 AD disease is not a disease that affects only one system. Patients with concurrent atopic comorbidities such as asthma may benefit from treatment with dupilumab (approved for the treatment of severe asthma), and patients with concurrent rheumatoid arthritis, spondyloarthropathies, alopecia areata or vitiligo may benefit most from JAK inhibition. The potential benefit of systemic treatment for other comorbidities such as neuropsychiatric complications known to be associated with AD disease needs to be further explored. Eczema that occurs in specific and high-stress sites, such as hand eczema and head and neck eczema, also requires further attention as there are relatively few studies addressing this focus. 5 Histamine, is a mediator in a variety of conditions, including hives, insect bite reactions, abnormal accumulation of MC's (mast cells) in the tissue, and drug spots. 6 Histamine-binding receptors are a family of G protein-coupled receptors (GPCRs). To date, four subtypes of histamine receptors (H1-H4) have been identified. 7 Studies have shown that the H4 receptor is the most important histamine receptor responsible for the development of itch in AD. 8 In addition, the skin, is known to be an important site for immune inflammation as it is composed of different cell types that respond to bacterial pathogens [bacteria release endotoxins such as lipopolysaccharide (LPS)] and therefore trigger inflammatory responses when they encounter each other. 9 In cutaneous dermatoses, the factors that trigger itching cause somatosensory neurons to open TRP channels, which then d -Abstract Truncated-
immunology